Azide-Hexanoyl-Val-Cit-PAB(m-PEG8)-MMAE Size:1mg 334 Purity (HPLC) >= 95%

334 Purity (HPLC) >= 95% Solubility DMSO

46 SMILES O=C(CCN1C(=O)C=CC1=O)NCCC(=O)N1CC2=CC=CC=C2C#CC2=CC=CC=C12 Purity (HPLC) >= 95% Shipping Conditions Room temperature Storage Conditions Refrigerated Shelf Life 12 months after the date of delivery Regulatory Statement For Research Use Only

031 SMILES CC(C)(C)OC(=O)CN1CCN(CC(=O)NCCCCCNC(=O)CCN2C(=O)C=CC2=O)CCN(CC(=O)OC(C)(C)C)CCN(CC(=O)OC(C)(C)C)CC1 Purity (HPLC) >= 95% Shipping Conditions Room temperature Storage Conditions Refrigerated Shelf Life 12 months after the date of delivery Regulatory Statement For Research Use Only

Product Name DOTA-tris(t-Bu)ester-PEG2-C2-propanamido-maleimide Synonyms CAS Number n/a Related CAS Molecular Formula C41H71N7O12 Molecular Weight 854

85 SMILES Cl

Azide-Hexanoyl-Val-Cit-PAB(m-PEG8)-MMAE Size:1mg 334 Purity (HPLC) >= 95%SOLU KNEX cleavable linker features a Val Cit dipeptide. m PEG8 is attached to the commonly used self immolative para aminobenzyl (PAB) moiety to increase aqueous solubility. The payload is monomethyl auristatin E (MMAE), a highly potent antimitotic agent that inhibits tubulin polymerization, leading to cell cycle arrest and subsequent apoptosis. Derived from established ADC linker architectures, SOLU KNEX ADC linkers integrate solubilizing